Adams, S., Schmid, P., Rugo, H. S., Winer, E. P., Loirat, D., Awada, A., Cescon, D. W., Iwata, H., Campone, M., Nanda, R., Hui, R., Curigliano, G., Toppmeyer, D., O'Shaughnessy, J., Loi, S., Paluch-Shimon, S., Tan, A. R., Card, D., Zhao, J., Karantza, V., & Cortés, J. (2019). pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study. Annals of oncology, 30, 397–404. http://access.bl.uk/ark:/81055/vdc_100094050962.0x000034